Trevena
TRVN
#10609
Rank
C$0.01 M
Marketcap
C$0.01658
Share price
0.00%
Change (1 day)
-99.28%
Change (1 year)

Trevena (TRVN) - Cash on Hand

Cash on Hand as of September 2024 : C$18.59 Million

According to Trevena's latest financial reports the company has C$18.59 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Trevena - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$43.73 M-15.89%
2022-12-31C$51.99 M-39.03%
2021-12-31C$85.28 M-38.86%
2020-12-31C$0.13 B198.3%
2019-12-31C$46.76 M-44.16%
2018-12-31C$83.75 M0.78%
2017-12-31C$83.1 M-44.09%
2016-12-31C$0.14 B-37.94%
2015-12-31C$0.23 B93.04%
2014-12-31C$0.12 B206.97%
2013-12-31C$40.41 M503.11%
2012-12-31C$6.7 M-61.39%
2011-12-31C$17.35 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
C$13.04 B 70,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$1.32 B 7,050.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
C$52.36 M 181.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$25.16 B 135,199.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
C$12.95 M-30.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA